TNFSF13 and plasma cell myeloma: Similar to the function reported for membrane CD138, which provides survival advantage to myeloma or plasma cells by potentiating APRIL signaling (43), we also found an enhancement of APRIL function in inducing ERK activation and B-cell differentiation when soluble CD138 is present.